Edition:
United Kingdom

Glaukos Corp (GKOS.N)

GKOS.N on New York Stock Exchange

58.84USD
21 Sep 2018
Change (% chg)

$-1.61 (-2.66%)
Prev Close
$60.45
Open
$60.28
Day's High
$60.73
Day's Low
$58.22
Volume
325,860
Avg. Vol
142,770
52-wk High
$70.79
52-wk Low
$23.10

Chart for

About

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision... (more)

Overall

Beta: --
Market Cap(Mil.): $1,156.64
Shares Outstanding(Mil.): 34.43
Dividend: --
Yield (%): --

Financials

  GKOS.N Industry Sector
P/E (TTM): -- 32.30 32.76
EPS (TTM): -0.04 -- --
ROI: -0.98 13.94 14.61
ROE: -0.98 16.79 16.33

BRIEF-Glaukos Q1 Loss Per Share $0.08

* GLAUKOS CORP ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

Competitors

Earnings vs. Estimates